00:00It's Benzinga, bringing Wall Street to Main Street.
00:02President Trump disclosed stock purchases worth up to $680,000 in Eli Lilly
00:08as his administration advanced policies benefiting the drug maker's obesity drug business.
00:14KFF Health News reported that Trump's disclosure forms show seven purchases of Eli Lilly shares
00:19between January 6th and the end of March. The purchases came as his administration
00:25advanced Medicare policies tied to obesity treatments. The proposed program was seen
00:29as a temporary bridge to permanent Medicare reimbursement for weight loss treatments
00:34with drug maker applications due by January 8th. Trump also disclosed a February 10th purchase
00:39of West Pharmaceutical Services shares worth between $250,000 and $500,000. A Trump organization
00:47spokesperson told Reuters the investments are held in a trust controlled by his children
00:51and managed through discretionary accounts by third-party financial institutions
00:55using automated trading systems. For all things money, visit Benzinga.com.
Comments